Search

everythinglearnresearchcommunity

for

Search:↓

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

The study identified key immune cell differences between mild and severe alopecia areata.

Red tattoo ink may cause skin growths, needing careful monitoring.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

AI can help diagnose Follicular Lymphoma by accurately identifying specific cell types.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

People with alopecia areata are more likely to have other immune-related conditions.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Alopecia areata may be treated by targeting immune system imbalances.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.